Treating multiple sclerosis: looking to the gut microbiome for answers
A synthetic version of a microRNA located in the gut microbiome has demonstrated effectiveness in suppressing multiple sclerosis-like symptoms in preclinical mouse models of the disease.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>